vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and VisionWave Holdings, Inc. (VWAV). Click either name above to swap in a different company.

VisionWave Holdings, Inc. is the larger business by last-quarter revenue ($10.0M vs $9.5M, roughly 1.1× Cellectis S.A.). VisionWave Holdings, Inc. runs the higher net margin — -69.4% vs -265.9%, a 196.5% gap on every dollar of revenue.

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

CoMix Wave Films, Inc. is a Japanese independent animation film studio and distribution company based in Chiyoda, Tokyo, Japan. The studio is known for its anime feature films, short films, and television commercials, particularly those made by director Makoto Shinkai. It was founded in March 2007 when it split from CoMix Wave Inc., which was initially formed in 1998 from Itochu Corporation, ASATSU, and other companies. On 15 October 2024, Toho announced that they'd acquired 45 shares or 6.0...

CLLS vs VWAV — Head-to-Head

Bigger by revenue
VWAV
VWAV
1.1× larger
VWAV
$10.0M
$9.5M
CLLS
Higher net margin
VWAV
VWAV
196.5% more per $
VWAV
-69.4%
-265.9%
CLLS

Income Statement — Q2 FY2024 vs Q1 FY2026

Metric
CLLS
CLLS
VWAV
VWAV
Revenue
$9.5M
$10.0M
Net Profit
$-25.3M
$-6.9M
Gross Margin
Operating Margin
-181.1%
-65.7%
Net Margin
-265.9%
-69.4%
Revenue YoY
375.0%
Net Profit YoY
-51.9%
-1522.6%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
VWAV
VWAV
Q4 25
$10.0M
Q2 24
$9.5M
Q3 23
$1.6M
Q2 23
$2.0M
Q2 22
$2.7M
Net Profit
CLLS
CLLS
VWAV
VWAV
Q4 25
$-6.9M
Q2 24
$-25.3M
Q3 23
$-17.5M
Q2 23
$-16.6M
Q2 22
$-19.5M
Gross Margin
CLLS
CLLS
VWAV
VWAV
Q4 25
Q2 24
Q3 23
Q2 23
97.3%
Q2 22
87.9%
Operating Margin
CLLS
CLLS
VWAV
VWAV
Q4 25
-65.7%
Q2 24
-181.1%
Q3 23
-1258.1%
Q2 23
-1180.5%
Q2 22
-1003.0%
Net Margin
CLLS
CLLS
VWAV
VWAV
Q4 25
-69.4%
Q2 24
-265.9%
Q3 23
-1064.1%
Q2 23
-831.6%
Q2 22
-714.4%
EPS (diluted)
CLLS
CLLS
VWAV
VWAV
Q4 25
Q2 24
$-0.28
Q3 23
$-0.31
Q2 23
$-0.20
Q2 22
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
VWAV
VWAV
Cash + ST InvestmentsLiquidity on hand
$149.0M
$15.7K
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
$3.1M
Total Assets
$407.1M
$18.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
VWAV
VWAV
Q4 25
$15.7K
Q2 24
$149.0M
Q3 23
Q2 23
$84.4M
Q2 22
$129.4M
Stockholders' Equity
CLLS
CLLS
VWAV
VWAV
Q4 25
$3.1M
Q2 24
$148.6M
Q3 23
$76.1M
Q2 23
$96.6M
Q2 22
$180.5M
Total Assets
CLLS
CLLS
VWAV
VWAV
Q4 25
$18.4M
Q2 24
$407.1M
Q3 23
$209.7M
Q2 23
$227.7M
Q2 22
$320.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
VWAV
VWAV
Operating Cash FlowLast quarter
$28.9M
$-5.4M
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
VWAV
VWAV
Q4 25
$-5.4M
Q2 24
$28.9M
Q3 23
Q2 23
$-47.4M
Q2 22
$-60.2M
Free Cash Flow
CLLS
CLLS
VWAV
VWAV
Q4 25
Q2 24
$27.6M
Q3 23
Q2 23
$-47.9M
Q2 22
$-61.7M
FCF Margin
CLLS
CLLS
VWAV
VWAV
Q4 25
Q2 24
290.5%
Q3 23
Q2 23
-2391.4%
Q2 22
-2266.7%
Capex Intensity
CLLS
CLLS
VWAV
VWAV
Q4 25
Q2 24
13.2%
Q3 23
Q2 23
24.1%
Q2 22
56.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons